Get the full picture
Sign in to uncover key details.
Show More
Bios Partners
Finance · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1751 River Run Ste 400, Fort Worth, Texa...Phone Number
(817) 345-6844Website
www.biospartners.comRevenue
<$5 MillionIndustry
About Bios Partners
Bios Partners is a venture capital firm focused on identifying and bringing advanced biotech innovations to market in the U.S. They aim to disrupt geographic favoritism in venture capital by investing in compelling scientific opportunities across the Central U.S. that are often overlooked. Their portfolio includes clinical-stage companies developing novel therapeutics for various medical conditions, including cancer and neurodegenerative disorders. With a team boasting 80 years of combined experience in hedge funds, private equity, and clinical drug development, they are well-equipped to support the growth of their investments.Explore more
Bios Partners Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Bios Partners
Compare insights from companies similar to Bios Partners, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bios Partners Tech Stack
A closer look at the technologies used by Bios Partners
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bios Partners
Sign Up For FreeTo access detailed company insights
Bios Partners is a venture capital firm focused on identifying and bringing advanced biotech innovations to market in the U.S. They aim to disrupt geographic favoritism in venture capital by investing in compelling scientific opportunities across the Central U.S. that are often overlooked. Their portfolio includes clinical-stage companies developin... Read More
